| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 16,812 | 16,825 | 14,197 | 14,397 | | Cost of Revenue | 9,947 | 9,490 | 8,718 | 8,670 | | | Gross Profit | 6,865 | 7,335 | 5,479 | 5,727 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,736 | 7,354 | 7,408 | 6,251 | | Non Recurring |
-
|
-
|
-
| 8,202 | | Others | 506 | 491 | 474 | (3,379) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (377) | (510) | (2,403) | (5,347) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 95 | 147 | 97 | (101) | | Earnings Before Interest And Taxes | (282) | (363) | (2,306) | (5,448) | | Interest Expense | 17 | 25 |
-
|
-
| | Income Before Tax | (299) | (388) | (2,306) | (5,448) | | Income Tax Expense | 228 | (38) | (122) | (450) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (527) | (350) | (2,184) | (4,998) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (527) | (350) | (2,184) | (4,998) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($527) | ($350) | ($2,184) | ($4,998) |
|
0.49% Nasdaq 
Income Statement
